Wexbill Pharmaceuticals Private Limited
About Wexbill Pharmaceuticals Private Limited
Data last updated:
Wexbill Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 30 April 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2016PTC298783.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Manish Kumar Singh and Susmita Kumari.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at Flat No 201 Rze 13 A Bengali Colony Mahavir Enclave, New Delhi, Delhi, India – 110045.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Wexbill Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No 201 Rze 13 A Bengali Colony Mahavir Enclave, New Delhi, Delhi, India – 110045
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Wexbill Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Wexbill Pharmaceuticals Private Limited
FY 2020 filings availableFinancial Statement Summary
| Metrics | FY 2016-17 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2016-17 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Wexbill Pharmaceuticals Private Limited, buy the company report.
Board of directors of Wexbill Pharmaceuticals Private Limited
Wexbill Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manish Kumar Singh | Director | 30 Apr 2016 | 10 Years 6 Months | Current |
| Susmita Kumari | Director | 26 Apr 2023 | 3 Years 6 Months | Current |
Auditor
Wexbill Pharmaceuticals Private Limited is audited by SARVAJEET SINGH AND CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SARVAJEET SINGH AND CO | FY 2017 | 014077C |
Shareholding
The shareholding of Wexbill Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Wexbill Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Wexbill Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Wexbill Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Wexbill Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Wexbill Pharmaceuticals Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Vikash Kumar Singh ceased to be Director on 28 Apr 2023.
Frequently asked questions
Wexbill Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in specialty, within the trading industry. It was incorporated on 30 April 2016 (10+ years old) and is registered under CIN U51909DL2016PTC298783.
Wexbill Pharmaceuticals has 2 current directors:
- Manish Kumar Singh - Director
- Susmita Kumari - Director
The latest financial statements of Wexbill Pharmaceuticals on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from FY 2017 are in the company report.
The CIN (Corporate Identification Number) of Wexbill Pharmaceuticals is U51909DL2016PTC298783. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Wexbill Pharmaceuticals was incorporated on 30 April 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
Vikash Kumar Singh ceased to be Director on 28 Apr 2023. Susmita Kumari was appointed as Director on 26 Apr 2023. Manish Kumar Singh was appointed as Director on 30 Apr 2016.
The registered office of Wexbill Pharmaceuticals is at Flat No 201 Rze 13 A Bengali Colony Mahavir Enclave, New Delhi, Delhi, India – 110045.
Wexbill Pharmaceuticals operates in the trading industry, in the specialty segment.
The compliance status of Wexbill Pharmaceuticals is compliant as of 24 July 2026. The company is actively filing with the Registrar of Companies.
Wexbill Pharmaceuticals can be reached at its registered office: Flat No 201 Rze 13 A Bengali Colony Mahavir Enclave, New Delhi, Delhi, India – 110045.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
